These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26553870)

  • 1. Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis.
    Iwasaki A; Sakai K; Moriya K; Sasaki T; Keene DR; Akhtar R; Miyazono T; Yasumura S; Watanabe M; Morishita S; Sakai T
    J Biol Chem; 2016 Jan; 291(1):72-88. PubMed ID: 26553870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-β.
    Kawelke N; Vasel M; Sens C; Au Av; Dooley S; Nakchbandi IA
    PLoS One; 2011; 6(11):e28181. PubMed ID: 22140539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells.
    Kumar P; Smith T; Raeman R; Chopyk DM; Brink H; Liu Y; Sulchek T; Anania FA
    J Biol Chem; 2018 Aug; 293(33):12781-12792. PubMed ID: 29941453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
    Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidase.
    Zhang Y; Ghazwani M; Li J; Sun M; Stolz DB; He F; Fan J; Xie W; Li S
    Biochem Biophys Res Commun; 2014 Apr; 446(4):940-4. PubMed ID: 24650661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting myosin 1c inhibits murine hepatic fibrogenesis.
    Arif E; Wang C; Swiderska-Syn MK; Solanki AK; Rahman B; Manka PP; Coombes JD; Canbay A; Papa S; Nihalani D; Aspichueta P; Lipschutz JH; Syn WK
    Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1044-G1053. PubMed ID: 33908271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice.
    Liu SB; Ikenaga N; Peng ZW; Sverdlov DY; Greenstein A; Smith V; Schuppan D; Popov Y
    FASEB J; 2016 Apr; 30(4):1599-609. PubMed ID: 26700732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes collagen cross-linking and ECM stiffening to induce liver fibrosis.
    Yue W; Zhang H; Gao Y; Ding J; Xue R; Dong C; Liu F; Yang L; Yang L; Li L
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167205. PubMed ID: 38696846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibronectin deposition improves experimental liver fibrosis.
    Altrock E; Sens C; Wuerfel C; Vasel M; Kawelke N; Dooley S; Sottile J; Nakchbandi IA
    J Hepatol; 2015 Mar; 62(3):625-33. PubMed ID: 24946284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT-5A regulates TGF-β-related activities in liver fibrosis.
    Beljaars L; Daliri S; Dijkhuizen C; Poelstra K; Gosens R
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G219-G227. PubMed ID: 28057611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
    Lu J; Zhang J; Wang Y; Sun Q
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matricellular protein periostin contributes to hepatic inflammation and fibrosis.
    Huang Y; Liu W; Xiao H; Maitikabili A; Lin Q; Wu T; Huang Z; Liu F; Luo Q; Ouyang G
    Am J Pathol; 2015 Mar; 185(3):786-97. PubMed ID: 25541330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
    Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hsu WH; Liao SC; Chyan YJ; Huang KW; Hsu SL; Chen YC; Siu ML; Chang CC; Chung YS; Huang CF
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis.
    Sakai K; Jawaid S; Sasaki T; Bou-Gharios G; Sakai T
    Am J Pathol; 2014 Oct; 184(10):2611-7. PubMed ID: 25108224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamyl-prolyl-tRNA synthetase induces fibrotic extracellular matrix via both transcriptional and translational mechanisms.
    Song DG; Kim D; Jung JW; Nam SH; Kim JE; Kim HJ; Kim JH; Lee SJ; Pan CH; Kim S; Lee JW
    FASEB J; 2019 Mar; 33(3):4341-4354. PubMed ID: 30592630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin in human liver disease and murine models of liver fibrosis-A protective factor against liver fibrosis.
    Alsamman M; Sterzer V; Meurer SK; Sahin H; Schaeper U; Kuscuoglu D; Strnad P; Weiskirchen R; Trautwein C; Scholten D
    Liver Int; 2018 May; 38(5):858-867. PubMed ID: 28941022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1q/tumor necrosis factor-related protein-3 acts as a target treating hepatic fibrosis.
    Sun BR; Li HY; Wang GP; Jia QA; Zhang C
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(17):5374-5382. PubMed ID: 34533812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic liver injury, TGF-beta, and cancer.
    Bissell DM
    Exp Mol Med; 2001 Dec; 33(4):179-90. PubMed ID: 11795478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation.
    Olsen AL; Bloomer SA; Chan EP; Gaça MD; Georges PC; Sackey B; Uemura M; Janmey PA; Wells RG
    Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G110-8. PubMed ID: 21527725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.